Literature DB >> 10466813

The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface.

Diane Wilcock1, Stephen A Duncan1, Paula Traktman2, Wei-Hong Zhang1, Geoffrey L Smith1.   

Abstract

Gene A40R from vaccinia virus (VV) strain Western Reserve has been characterized. The open reading frame (ORF) was predicted to encode a 159 amino acid, 18152 Da protein with amino acid similarity to C-type animal lectins and to the VV A34R protein, a component of extracellular enveloped virus (EEV). Northern blotting and S1 nuclease mapping showed that gene A40R is transcribed early during infection from a position 12 nucleotides upstream of the ORF, producing a transcript of approximately 600 nucleotides. Rabbit anti-sera were raised against bacterial fusion proteins containing parts of the A40R protein. These were used to identify an 18 kDa primary translation product and N- and O-glycosylated forms of 28, 35 and 38 kDa. The A40R proteins were detected early during infection, formed higher molecular mass complexes under non-reducing conditions and were present on the cell surface but absent from virions. The proteins partitioned with integral membrane proteins in Triton X-114. Canine pancreatic microsomal membranes protected in vitro-translated A40R from proteinase K digestion, suggesting the A40R protein has type II membrane topology. A mutant virus with the A40R gene disrupted after amino acid 50, so as to remove the entire lectin-like domain, and a revertant virus were constructed. Disruption of the A40R gene did not affect virus plaque size, in vitro growth rate and titre, EEV formation, or virus virulence in a murine intranasal model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466813     DOI: 10.1099/0022-1317-80-8-2137

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Genome of deerpox virus.

Authors:  C L Afonso; G Delhon; E R Tulman; Z Lu; A Zsak; V M Becerra; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains.

Authors:  Hua-Poo Su; Kavita Singh; Apostolos G Gittis; David N Garboczi
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

3.  Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association.

Authors:  Silvia Palacios; Laurent H Perez; Sonja Welsch; Sibylle Schleich; Katarzyna Chmielarska; Frauke Melchior; Jacomine Krijnse Locker
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

4.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus.

Authors:  S Voigt; G R Sandford; L Ding; W H Burns
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  The genome of fowlpox virus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Evolution of and evolutionary relationships between extant vaccinia virus strains.

Authors:  Li Qin; Nicole Favis; Jakub Famulski; David H Evans
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

8.  The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.

Authors:  Jonathan S Duke-Cohan; Kristin Wollenick; Elizabeth A Witten; Michael S Seaman; Lindsey R Baden; Raphael Dolin; Ellis L Reinherz
Journal:  Vaccine       Date:  2009-01-13       Impact factor: 3.641

9.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  The genome of Chelonid herpesvirus 5 harbors atypical genes.

Authors:  Mathias Ackermann; Maxim Koriabine; Fabienne Hartmann-Fritsch; Pieter J de Jong; Teresa D Lewis; Nelli Schetle; Thierry M Work; Julie Dagenais; George H Balazs; Jo-Ann C Leong
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.